These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33668726)

  • 1. Identifying Clusters of Adherence to Cardiovascular Risk Reduction Behaviors and Persistence with Medication in New Lipid-Lowering Drug Users. Impact on Healthcare Utilization.
    Malo S; Rabanaque MJ; Maldonado L; Moreno-Franco B; Chaure-Pardos A; Lallana MJ; Rodrigo MP; Aguilar-Palacio I
    Nutrients; 2021 Feb; 13(3):. PubMed ID: 33668726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of Mediterranean diet and physical activity in secondary cardiovascular disease prevention: results from the UCC-SMART cohort study.
    Bonekamp NE; Visseren FLJ; van der Schouw YT; van der Meer MG; Teraa M; Ruigrok YM; Geleijnse JM; Koopal C;
    Eur J Prev Cardiol; 2024 Sep; 31(12):1460-1468. PubMed ID: 38547043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults.
    Palmer MJ; Barnard S; Perel P; Free C
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012675. PubMed ID: 29932455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between refill adherence to lipid-lowering medications and the risk of cardiovascular disease and mortality in Swedish patients with type 2 diabetes mellitus: a nationwide cohort study.
    Karlsson SA; Hero C; Svensson AM; Franzén S; Miftaraj M; Gudbjörnsdottir S; Eeg-Olofsson K; Eliasson B; Andersson Sundell K
    BMJ Open; 2018 Mar; 8(3):e020309. PubMed ID: 29602853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults.
    Palmer MJ; Machiyama K; Woodd S; Gubijev A; Barnard S; Russell S; Perel P; Free C
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD012675. PubMed ID: 33769555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Healthy Lifestyle for Prevention of Premature Death Among Users and Nonusers of Common Preventive Medications: A Prospective Study in 2 US Cohorts.
    Wang K; Li Y; Liu G; Rimm E; Chan AT; Giovannucci EL; Song M
    J Am Heart Assoc; 2020 Jul; 9(13):e016692. PubMed ID: 32578485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Cardiovascular Patient Groups at Risk for Poor Medication Adherence: A Cluster Analysis.
    Sieben A; A W van Onzenoort H; J H M van Laarhoven K; Bredie SJH; van Dulmen S
    J Cardiovasc Nurs; 2021 Sep-Oct 01; 36(5):489-497. PubMed ID: 32501862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender-specific, Lifestyle-related Factors and 10-year Cardiovascular Disease Risk; the ATTICA and GREECS Cohort Studies.
    Kouvari M; Panagiotakos DB; Chrysohoou C; Georgousopoulou E; Notara V; Tousoulis D; Pitsavos C; Attica Greecs Studies Investigators
    Curr Vasc Pharmacol; 2019; 17(4):401-410. PubMed ID: 29886832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Male Users of Lipid-Lowering Drugs for Primary Prevention of Cardiovascular Disease: The Impact of Treatment Persistence on Morbimortality. A Longitudinal Study.
    Aguilar-Palacio I; Rabanaque MJ; Maldonado L; Chaure A; Abad-Díez JM; León-Latre M; Casasnovas JA; Malo S
    Int J Environ Res Public Health; 2020 Oct; 17(20):. PubMed ID: 33092211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships among medication adherence, lifestyle modification, and health-related quality of life in patients with acute myocardial infarction: a cross-sectional study.
    Lee YM; Kim RB; Lee HJ; Kim K; Shin MH; Park HK; Ahn SK; Kim SY; Lee YH; Kim BG; Lee H; Lee WK; Lee KS; Kim MJ; Park KS
    Health Qual Life Outcomes; 2018 May; 16(1):100. PubMed ID: 29788961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refill adherence and persistence to lipid-lowering medicines in patients with type 2 diabetes: A nation-wide register-based study.
    Karlsson SA; Hero C; Eliasson B; Franzén S; Svensson AM; Miftaraj M; Gudbjörnsdottir S; Eeg-Olofsson K; Andersson Sundell K
    Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1220-1232. PubMed ID: 28799214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mobile phone text messaging for medication adherence in secondary prevention of cardiovascular disease.
    Redfern J; Tu Q; Hyun K; Hollings MA; Hafiz N; Zwack C; Free C; Perel P; Chow CK
    Cochrane Database Syst Rev; 2024 Mar; 3(3):CD011851. PubMed ID: 38533994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different approaches to the assessment of adherence and persistence with cardiovascular-disease preventive medications.
    Malo S; Aguilar-Palacio I; Feja C; Lallana MJ; Rabanaque MJ; Armesto J; Menditto E
    Curr Med Res Opin; 2017 Jul; 33(7):1329-1336. PubMed ID: 28422521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Lipid-Lowering and Antihypertensive Treatments in Addition to Healthy Lifestyles in Primary Prevention: An Analysis of the HOPE-3 Trial.
    Dagenais GR; Jung H; Lonn E; Bogaty PM; Dehghan M; Held C; Avezum A; Jansky P; Keltai M; Leiter LA; Lopez-Jaramillo P; Toff WD; Bosch J; Yusuf S
    J Am Heart Assoc; 2018 Jul; 7(15):. PubMed ID: 30033433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Mediterranean lifestyle reduces the risk of cardiovascular disease in the "Seguimiento Universidad de Navarra" (SUN) cohort.
    Mata-Fernández A; Hershey MS; Pastrana-Delgado JC; Sotos-Prieto M; Ruiz-Canela M; Kales SN; Martínez-González MA; Fernandez-Montero A
    Nutr Metab Cardiovasc Dis; 2021 Jun; 31(6):1728-1737. PubMed ID: 33895077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to lipid-lowering therapy and risk for cardiovascular disease and death in type 1 diabetes mellitus: a population-based study from the Swedish National Diabetes Register.
    Hero C; Karlsson SA; Franzén S; Svensson AM; Miftaraj M; Gudbjörnsdottir S; Andersson Sundell K; Eliasson B; Eeg-Olofsson K
    BMJ Open Diabetes Res Care; 2020 Jan; 8(1):. PubMed ID: 31958300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lifestyle Changes in Relation to Initiation of Antihypertensive and Lipid-Lowering Medication: A Cohort Study.
    Korhonen MJ; Pentti J; Hartikainen J; Ilomäki J; Setoguchi S; Liew D; Kivimäki M; Vahtera J
    J Am Heart Assoc; 2020 Feb; 9(4):e014168. PubMed ID: 32019405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mediterranean Diet Adherence, Physical Activity, and Advanced Glycation End Products in Complex PTSD: A Comprehensive Examination of Lifestyle and Cardiovascular Risk in War Veterans.
    Puljiz Z; Kumric M; Borovina Marasovic T; Mastelic T; Rakusic M; Pavela G; Beg A; Glavina T; Mornar M; Supe Domic D; Vilovic M; Zucko J; Ticinovic Kurir T; Bozic J
    Nutrients; 2024 Jun; 16(11):. PubMed ID: 38892723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term prognostic value of LDL-C, HDL-C, lp(a) and TG levels on cardiovascular disease incidence, by body weight status, dietary habits and lipid-lowering treatment: the ATTICA epidemiological cohort study (2002-2012).
    Georgoulis M; Chrysohoou C; Georgousopoulou E; Damigou E; Skoumas I; Pitsavos C; Panagiotakos D
    Lipids Health Dis; 2022 Dec; 21(1):141. PubMed ID: 36529737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving adherence to lipid-lowering therapy in a community pharmacy intervention program: a cost-effectiveness analysis.
    Vegter S; Oosterhof P; van Boven JF; Stuurman-Bieze AG; Hiddink EG; Postma MJ
    J Manag Care Spec Pharm; 2014 Jul; 20(7):722-32. PubMed ID: 24967525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.